S&P 500 Rebounds as Investors Focus on 2025-Q2
The S&P 500 (Index: SPX) rebounded in the pre-Thanksgiving holiday week of trading. The index rose 1.7% from where it ended the previous week, closing at 5,969.34 on Friday, 22 November 2024.
The biggest driver of stock prices continues to be expectations for how the Federal Reserve will be setting interest rates in 2025. The CME Group’s FedWatch Tool continues to anticipate the Fed will reduce the Federal Funds Rate by 0.25% when its Federal Open Market Committee concludes a two day meeting on 18 December 2024. More significantly, the FedWatch tool’s projections for all of 2025 indicate just one more rate cut is expected, a quarter point reduction on 18 June (2025-Q2). The tool expects the Federal Funds Rate will bottom at a target range of 4.00-4.25%.
Since that single rate cut now expected in 2025 would take place in 2025-Q2, that explains why investors are focusing on that distant future quarter as they set current day stock prices. The latest update of the alternative futures chart shows the trajectory of the S&P 500 just below the bottom of the range that we would expect to most likely find it for when investors focus their forward looking attention on 2025-Q2.
Since the alternative futures are projected to dip below where the S&P 500 is currently positioned in the week ahead, we can argue the market regime that has been in place since 9 March 2023 is still holding. We’re still keeping an eye out for indications of a change in market regime.
With the Thanksgiving Day holiday weekend coming up, we anticipate a slow flow of market moving news in the week ahead. Here are the past week’s market moving headlines:
- Monday, 18 November 2024
-
- Signs and portents for the U.S. economy:
- Oil prices rise over 3% on Sverdrup outage, Ukraine war escalation
- US single-family housing starts slump; high mortgage rates remain a challenge
- Fed minions find more untamed inflation to fight:
- US labor market still boosting inflation, San Francisco Fed economists say
- Fed hawks and doves: what US central bankers are saying
- Bigger trouble developing in China:
- China’s export tax bombshell rocks aluminium market
- Chinese exporters to hike prices, renegotiate contracts after tax rebate cuts, sources say
- BOJ minions setting stage to leave interest rates unchanged, claim they’ll stop stimulus someday:
- BOJ sees progress in wage-driven inflation, keeps Dec rate hike on table
- BOJ to bid farewell to stimulus era, justify rate hikes in policy review
- ECB minions more worried about inadequate growth than inflation from tariffs:
- ECB fears Trump tariff effect on growth more than on inflation
- ECB’s Nagel says Trump’s tariffs may have minor impact on inflation
- ECB’s Makhlouf: Premature to make decisions based on new U.S. administration
- Nasdaq and S&P advance, Dow slides and yields stumble
- Tuesday, 19 November 2024
-
- Signs and portents for the U.S. economy:
- Fed minions say they don’t know how much longer they’ll cut interest rates:
- Bigger trouble, stimulus developing in China:
- ECB minions getting excited to cut Eurozone interest rates again:
- Nasdaq up 1%, S&P 500 ends higher as tech moves limit Russia-Ukraine pressure; Dow slips
- Wednesday, 20 November 2024
-
- Signs and portents for the U.S. economy:
- Oil little changed as market weighs mixed drivers
- OPEC+ may stick with deep oil cuts for longer due to weak demand
- Fed minions still expected to deliver December rate cut, uncertain on inflation, future rate cuts:
- Fed to lower rates in Dec but slow pace in 2025 on inflation risks: Reuters poll
- Fed governors stake out competing views of inflation risk
- Fed’s Williams sees inflation cooling and interest rates falling further, Barron’s reports
- Fed’s Collins sees more rate cuts ahead for US central bank
- Fed’s Bowman says rate cuts are concerning
- Fed’s Bowman calls for cautious approach on interest rates
- Bigger trouble developing in China:
- China leaves lending benchmark LPRs unchanged, as expected
- Trump to unleash nearly 40% tariffs on China in early 2025, hitting growth: Reuters poll
- Chinese companies find solution to falling population:
- ECB minions find new problem to worry about:
- Wall Street ends mixed, Nvidia shares slip after the bell
- Thursday, 21 November 2024
-
- Signs and portents for the U.S. economy:
- Oil up 2% after Russia-Ukraine missile exchange, outweighing US crude stock rises
- US natural gas drillers to lift 2025 output, reversing year of cuts
- US existing home sales rebound in October
- US 30-year fixed-rate mortgage approaches 7%
- Fed minions getting more worried about untamed Bidenflation:
- Fed’s Barkin says US is vulnerable to inflation shocks, FT reports
- Fed’s Goolsbee says pace of rate cuts may need to slow
- Bigger stimulus developing in China:
- ECB minions worry about Eurozone getting into more trade wars, thinking about how to grab more power:
- ECB warns of ‘sizeable’ hit to growth from a trade war
- Trump and Europe: ECB policymakers say EU must complete shelved projects to tackle threat
- Wall Street closes higher as Dow, S&P hit one-week tops
- Friday, 22 November 2024
-
- Signs and portents for the U.S. economy:
- Oil prices settle up 1% at 2-week high as Ukraine war intensifies
- US existing home sales rebound in October
- China signals its looking for trade deal with U.S.:
- BOJ minions signal they’ll attempt another rate hike to combat Japan inflation in December 2024:
- BOJ to hike rates in Dec as yen weakens and Trump returns, majority of analysts say: Reuters poll
- Japan’s inflation holds above BOJ target, fanning Dec rate hike bets
- Japan’s factory activity extends declines on sluggish demand, PMI shows
- ECB minions getting excited to deliver more rate cuts, wonder what to do with Germany as sick man of Eurozone:
- More ECB cuts are coming but Dec discussion must wait, Nagel says
- Vulnerable Germany heaps pressure on ECB
- Dow climbs 1%, S&P, Nasdaq advance as Wall Street’s key averages cement weekly wins
The Atlanta Fed’s GDPNow tool‘s projection of the real GDP growth rate for the current quarter of 2024-Q3 ticked up to +2.6% from the previous week’s +2.5%.
On a programming note, we’re going to break away for our annual celebration of the Thanksgiving holiday this week. The next edition of our
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon with a Wall Street bull and a bear playing basketball, with the bull rebounding”. We have to admit the AI did a great job with the bull. As for the bear, with how good the bull came out, we can only assume that AI believes bears are bad at basketball.
Source: https://politicalcalculations.blogspot.com/2024/11/s-500-rebounds-as-investors-focus-on.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.